RNTX
Rein Therapeutics
RNTX
RNTX
42 hedge funds and large institutions have $16.5M invested in Rein Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $18.9M → $16.5M (-$2.39M)
62% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 13
Holders
42
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$71K | |
| 2 | +$66K | |
| 3 | +$46K | |
| 4 |
Citigroup
New York
|
+$15K |
| 5 |
VF
Virtu Financial
New York
|
+$11K |
Top Sellers
| 1 | -$341K | |
| 2 | -$211K | |
| 3 | -$171K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$31.2K |
| 5 |
KWM
Keebeck Wealth Management
Chicago,
Illinois
|
-$22.3K |